BCNephro Logo

Monthly Archives: October 2024

Home|2024|October

Lipid Lowering Agents and the Kidney

Many, if not most patients with chronic kidney disease (CKD) will have indications and benefit from pharmacologic treatment of hyperlipidemia.  Despite this patients and some clinicians may have concerns about nephrotoxicity with use of these medications. This article will review the data regarding renal safety and the potential for adverse renal effects of

By |2024-10-31T12:56:58+00:00October 31st, 2024|Kidney Disease|0 Comments
Read More

Medication Induced Hypertension – Abiraterone

What Is Abiraterone? Abiraterone (Zytiga) is a medication used in the treatment of metastatic prostate cancer. It works by decreasing the production of androgens in the testes, adrenal glands and the prostate tumor (androgen deprivation therapy). Abiraterone inhibits the enzyme Cytochrome P450 C17A1 (CYP17A1).  This enzyme has two functions: 17𝝰-hydroxylase 17,20 lyase Inhibition

By |2024-10-09T13:12:17+00:00October 9th, 2024|Hypertension|0 Comments
Read More

About Dr. Cronin

Brian Cronin is board certified in Internal Medicine and Nephrology and has been designated by the American Society of Hypertension as a Clinical Specialist in Hypertension in 2005, redesignated in 2015.

Categories

Popular Blog Articles

Dialysis Rounding Primer – Introduction
Causes Of Nephrotic Syndrome, Evaluation Of Nephrotic Proteinuria
Hyponatremia: What The Labs Tell Us
What? I Have Stage 3 Kidney Disease!! Talking To Patients About GFR And CKD
Proteinuria: What Is It And How I Treat
Minimal Change Disease – Cause Of Nephrotic Syndrome
How Not To Mess Up A Kidney Transplant
Understanding Acid Base Disorders
Dialysis Access: Fistula Or Graft? How To Figure It Out
High K – What’s The Deal? How To Think About Hyperkalemia

© BCNephro | All rights reserved

Search Our Site

Go to Top